Transcatheter Pulmonary Valve Market by Technology (Balloon-Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), Raw Material (Synthetic Transcatheter Valve, Tissue Engineered Transcatheter Valve), Application, End Use - Global Forecast 2024-

Transcatheter Pulmonary Valve Market by Technology (Balloon-Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), Raw Material (Synthetic Transcatheter Valve, Tissue Engineered Transcatheter Valve), Application, End Use - Global Forecast 2024-2030


The Transcatheter Pulmonary Valve Market size was estimated at USD 63.53 million in 2023 and expected to reach USD 69.76 million in 2024, at a CAGR 9.90% to reach USD 123.08 million by 2030.

Global Transcatheter Pulmonary Valve Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transcatheter Pulmonary Valve Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transcatheter Pulmonary Valve Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transcatheter Pulmonary Valve Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Colibri Heart Valve, LLC, Commonwealth Edison Company, CryoLife, Inc., Direct Flow Medical, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medtronic PLC, SYMETIS, ValveXchange, Inc., Venus MedTech HangZhou Inc, and Xeltis AG.

Market Segmentation & Coverage

This research report categorizes the Transcatheter Pulmonary Valve Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
Balloon-Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
Raw Material
Synthetic Transcatheter Valve
Tissue Engineered Transcatheter Valve
Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Regurgitation
Pulmonary Stenosis
Tetralogy Of Fallot
Truncus Arteriosus
End Use
Adult
Pediatric
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transcatheter Pulmonary Valve Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transcatheter Pulmonary Valve Market?
3. What are the technology trends and regulatory frameworks in the Transcatheter Pulmonary Valve Market?
4. What is the market share of the leading vendors in the Transcatheter Pulmonary Valve Market?
5. Which modes and strategic moves are suitable for entering the Transcatheter Pulmonary Valve Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transcatheter Pulmonary Valve Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of various cardiovascular diseases
5.1.1.2. Growing population with heart valve disorders and surging demand for pulmonary valve replacement
5.1.1.3. Increasing awareness of transcatheter pulmonary valve therapy
5.1.2. Restraints
5.1.2.1. Stringent regulations for approval process
5.1.3. Opportunities
5.1.3.1. Technological advancement in valve replacement procedures
5.1.3.2. Growing number of product launches related to transcatheter heart valve technologies
5.1.4. Challenges
5.1.4.1. The availability of alternative technologies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Transcatheter Pulmonary Valve Market, by Technology
6.1. Introduction
6.2. Balloon-Expanded Transcatheter Valve
6.3. Self-Expanded Transcatheter Valve
7. Transcatheter Pulmonary Valve Market, by Raw Material
7.1. Introduction
7.2. Synthetic Transcatheter Valve
7.3. Tissue Engineered Transcatheter Valve
8. Transcatheter Pulmonary Valve Market, by Application
8.1. Introduction
8.2. Cardiac Anomaly
8.3. Pulmonary Atresia
8.4. Pulmonary Regurgitation
8.5. Pulmonary Stenosis
8.6. Tetralogy Of Fallot
8.7. Truncus Arteriosus
9. Transcatheter Pulmonary Valve Market, by End Use
9.1. Introduction
9.2. Adult
9.3. Pediatric
10. Americas Transcatheter Pulmonary Valve Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Transcatheter Pulmonary Valve Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Transcatheter Pulmonary Valve Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Boston Scientific Corporation
14.1.2. Colibri Heart Valve, LLC
14.1.3. Commonwealth Edison Company
14.1.4. CryoLife, Inc.
14.1.5. Direct Flow Medical, Inc.
14.1.6. Edwards Lifesciences Corporation
14.1.7. JenaValve Technology, Inc.
14.1.8. Jude Medical Inc.
14.1.9. Lepu Medical Technology (Beijing) Co., Ltd.
14.1.10. LivaNova PLC
14.1.11. Medtronic PLC
14.1.12. SYMETIS
14.1.13. ValveXchange, Inc.
14.1.14. Venus MedTech HangZhou Inc
14.1.15. Xeltis AG
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. TRANSCATHETER PULMONARY VALVE MARKET RESEARCH PROCESS
FIGURE 2. TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2023 VS 2030
FIGURE 3. TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSCATHETER PULMONARY VALVE MARKET DYNAMICS
FIGURE 7. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
FIGURE 10. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 14. TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings